Kronos Bio Inc. (KRON) Social Stream
KRONOS BIO INC (KRON) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KRON.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 3 | $50 | $36 | $40.666 | $1.24 | 3179.52% |
| 2021-12-06 | 4 | $50 | $36 | $40.666 | $1.24 | 3179.52% |
| 2021-12-22 | 4 | $50 | $25 | $37 | $1.24 | 2883.87% |
| 2022-02-24 | 4 | $50 | $22 | $36 | $1.24 | 2803.23% |
| 2022-05-04 | 4 | $36 | $22 | $29.333 | $1.24 | 2265.56% |
| 2022-05-08 | 4 | $36 | $17 | $27.666 | $1.24 | 2131.13% |
| 2022-05-23 | 4 | $36 | $13 | $22 | $1.24 | 1674.19% |
| 2022-08-04 | 5 | $36 | $13 | $22.25 | $1.24 | 1694.35% |
| 2022-08-09 | 5 | $36 | $13 | $21.75 | $1.24 | 1654.03% |
| 2022-09-14 | 6 | $36 | $12 | $19.8 | $1.24 | 1496.77% |
| 2022-11-08 | 5 | $36 | $12 | $19.8 | $1.24 | 1496.77% |
| 2022-11-10 | 6 | $36 | $7 | $16.8 | $1.24 | 1254.84% |
| 2022-12-08 | 6 | $15 | $7 | $11.6 | $1.24 | 835.48% |
| 2023-08-09 | 6 | $14 | $7 | $10.2 | $1.24 | 722.58% |
| 2023-08-21 | 6 | $14 | $7 | $10 | $1.24 | 706.45% |
| 2023-11-27 | 6 | $14 | $7 | $9.8 | $1.24 | 690.32% |
| 2023-12-19 | 6 | $14 | $2.5 | $8.3 | $1.24 | 569.35% |
The Trend in the Analyst Price Target
KRON's average price target has moved down $27.7 over the prior 22 months.
KRON reports an average of 676.56% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-12 | 6 | 14 | 7 | 10.2 | 2.47 | 312.96% |
| 2023-03-15 | 6 | 14 | 7 | 10.2 | 1.50 | 580% |
| 2023-04-17 | 6 | 14 | 7 | 10.2 | 1.36 | 650% |
| 2023-10-24 | 6 | 14 | 7 | 9.8 | 0.87 | 1026.44% |
| 2023-11-14 | 6 | 14 | 7 | 9.8 | 0.75 | 1206.67% |
KRON Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 31 weeks, KRON's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- KRONOS BIO INC's upside potential (average analyst target price relative to current price) is higher than 1763.37% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, KRONOS BIO INC's variance in analysts' estimates is lower than -1314.97% of them.
- KRONOS BIO INC's number of analysts covering the stock is greater than 450.37% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, KRONOS BIO INC's average analyst price target is higher than 978.35% of them.
In the Pharmaceutical Products industry, SPRB, FHTX, and PRTC are the three stocks most similar to KRONOS BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is KRON a Buy, Hold or Sell? See the POWR Ratings now!